The first-of-its-kind study published last week in the the 'American Journal of Clinical Nutrition' was conducted by Italian researchers among over 1,000 participants.
Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.
Developed by US firm Merck & Co, Sitagliptin is used to treat Type 2 diabetes, a condition in which blood sugar goes up because the body does not produce or use insulin normally.
The ICMR has called a virtual meeting of pharma companies and NGOs to discuss the high pricing of cancer, diabetic, thyroid drugs, among others, on 17 August.
On bilateral ties, Admiral Paparo said India-US ties have an exponential effect on deterrence, because it demonstrates a unity of purpose among us to maintain the peace.
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.
COMMENTS